ALK amplifications occurred only in stage 3 (4/28, 14.3%) and stage 4 (10/234, 4.3%) neuroblastomas, and were significantly enriched in stage 3 compared to non-stage 3 tumors (14.3% versus 3.7%, P = 0.032, Fig. 2c). Here, ALK is linked to neuroblastoma.